CVMP opinions on veterinary medicinal productsThe Committee adopted a positive opinion for a marketing authorisation for Nobivac NXT HCPChFeLV, for the active immunisation of…

Original title: “Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 April 2026”

EMA has recommended granting a marketing authorisation in the EU for Nobivac NXT HCPChFeLV, a vaccine for protecting cats against common infectious diseases.The vaccine…

Original title: “EMA recommends authorisation of first veterinary vaccine using RNA technology”

The findings, which come amid FDA scrutiny of Foundayo’s safety, will enable Lilly to seek a new clearance in diabetes.

Original title: “Lilly’s new obesity pill passes heart safety test in diabetes”

FDA is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism.

Original title: “FDA Takes Step Forward on Testosterone Therapy for Men”

Right after the FDA flagged safety concerns for Eli Lilly’s newly approved obesity pill, the pharma posted diabetes data demonstrating a clean safety profile and revealed plans to seek approval in the indication.

Original title: “Lilly’s Foundayo posts ‘outstanding’ diabetes data, possibly easing FDA safety concerns”